印度颗粒公司在美国FDA对违规行为警告后, 升级了制造监督. Granules India upgrades manufacturing oversight after U.S. FDA warning over compliance violations.

印度颗粒剂公司是全球主要的甲酸盐生产商, 在美国FDA警告之后正在加强其制造设施监督. Granules India, a major global paracetamol producer, is enhancing oversight at its manufacturing facilities following a U.S. FDA warning. 公司在泰兰加纳工厂违反了记录,设备清洁和污染控制. The agency cited violations at the company's Telangana plant regarding record-keeping, equipment cleaning, and contamination controls. 作为回应,Granules正在数字化文件,增加现场检查以及投资自动化以改善合规性并减少监管风险. In response, Granules is digitizing documents, increasing on-site inspections, and investing in automation to improve compliance and reduce regulatory risks.